Literature DB >> 28678625

Use of additives, scaffolds and extracellular matrix components for improvement of human pancreatic islet outcomes in vitro: A systematic review.

Natália Emerim Lemos1,2, Letícia de Almeida Brondani1,2, Cristine Dieter1,2, Jakeline Rheinheimer1,2, Ana Paula Bouças1, Cristiane Bauermann Leitão1,2, Daisy Crispim1,2, Andrea Carla Bauer1,2.   

Abstract

Pancreatic islet transplantation is an established treatment to restore insulin independence in type 1 diabetic patients. Its success rates have increased lately based on improvements in immunosuppressive therapies and on islet isolation and culture. It is known that the quality and quantity of viable transplanted islets are crucial for the achievement of insulin independence and some studies have shown that a significant number of islets are lost during culture time. Thus, in an effort to improve islet yield during culture period, researchers have tested a variety of additives in culture media as well as alternative culture devices, such as scaffolds. However, due to the use of different categories of additives or devices, it is difficult to draw a conclusion on the benefits of these strategies. Therefore, the aim of this systematic review was to summarize the results of studies that described the use of medium additives, scaffolds or extracellular matrix (ECM) components during human pancreatic islets culture. PubMed and Embase repositories were searched. Of 5083 articles retrieved, a total of 37 articles fulfilled the eligibility criteria and were included in the review. After data extraction, articles were grouped as follows: 1) "antiapoptotic/anti-inflammatory/antioxidant," 2) "hormone," 3) "sulphonylureas," 4) "serum supplements," and 5) "scaffolds or ECM components." The effects of the reviewed additives, ECM or scaffolds on islet viability, apoptosis and function (glucose-stimulated insulin secretion - GSIS) were heterogeneous, making any major conclusion hard to sustain. Overall, some "antiapoptotic/anti-inflammatory/antioxidant" additives decreased apoptosis and improved GSIS. Moreover, islet culture with ECM components or scaffolds increased GSIS. More studies are needed to define the real impact of these strategies in improving islet transplantation outcomes.

Entities:  

Keywords:  additives in cultures; culture of islets; extracellular matrix; human pancreatic islet; islet isolation; scaffolds

Mesh:

Substances:

Year:  2017        PMID: 28678625      PMCID: PMC5624286          DOI: 10.1080/19382014.2017.1335842

Source DB:  PubMed          Journal:  Islets        ISSN: 1938-2014            Impact factor:   2.694


  78 in total

1.  Long-Term Follow-Up of the Edmonton Protocol of Islet Transplantation in the United States.

Authors:  D C Brennan; H A Kopetskie; P H Sayre; R Alejandro; E Cagliero; A M J Shapiro; J S Goldstein; M R DesMarais; S Booher; P J Bianchine
Journal:  Am J Transplant       Date:  2015-10-03       Impact factor: 8.086

2.  MnTMPyP, a metalloporphyrin-based superoxide dismutase/catalase mimetic, protects INS-1 cells and human pancreatic islets from an in vitro oxidative challenge.

Authors:  C Moriscot; S Candel; V Sauret; J Kerr-Conte; M J Richard; M C Favrot; P Y Benhamou
Journal:  Diabetes Metab       Date:  2007-01-26       Impact factor: 6.041

3.  Human islet viability and function is maintained during high-density shipment in silicone rubber membrane vessels.

Authors:  J P Kitzmann; A R Pepper; B Gala-Lopez; R Pawlick; T Kin; D O'Gorman; K R Mueller; A C Gruessner; E S Avgoustiniatos; T Karatzas; G L Szot; A M Posselt; P G Stock; J R Wilson; A M Shapiro; K K Papas
Journal:  Transplant Proc       Date:  2014 Jul-Aug       Impact factor: 1.066

4.  Fabrication of three-dimensional bioplotted hydrogel scaffolds for islets of Langerhans transplantation.

Authors:  G Marchioli; L van Gurp; P P van Krieken; D Stamatialis; M Engelse; C A van Blitterswijk; M B J Karperien; E de Koning; J Alblas; L Moroni; A A van Apeldoorn
Journal:  Biofabrication       Date:  2015-05-28       Impact factor: 9.954

Review 5.  Point: steady progress and current challenges in clinical islet transplantation.

Authors:  Davide Mineo; Antonello Pileggi; Rodolfo Alejandro; Camillo Ricordi
Journal:  Diabetes Care       Date:  2009-08       Impact factor: 19.112

6.  Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets.

Authors:  Loredana Farilla; Angela Bulotta; Boaz Hirshberg; Sergio Li Calzi; Nasif Khoury; Houtan Noushmehr; Cristina Bertolotto; Umberto Di Mario; David M Harlan; Riccardo Perfetti
Journal:  Endocrinology       Date:  2003-08-28       Impact factor: 4.736

7.  Brain death significantly reduces isolated pancreatic islet yields and functionality in vitro and in vivo after transplantation in rats.

Authors:  Juan L Contreras; Christopher Eckstein; Cheryl A Smyth; Marty T Sellers; Mario Vilatoba; Guadalupe Bilbao; Firoz G Rahemtulla; Carlton J Young; J Anthony Thompson; Irshad H Chaudry; Devin E Eckhoff
Journal:  Diabetes       Date:  2003-12       Impact factor: 9.461

8.  Recovery from diabetes in mice by beta cell regeneration.

Authors:  Tomer Nir; Douglas A Melton; Yuval Dor
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

Review 9.  Physiology and emerging biochemistry of the glucagon-like peptide-1 receptor.

Authors:  Francis S Willard; Kyle W Sloop
Journal:  Exp Diabetes Res       Date:  2012-05-14

10.  Supplements in human islet culture: human serum albumin is inferior to fetal bovine serum.

Authors:  Efstathios S Avgoustiniatos; William E Scott; Thomas M Suszynski; Henk-Jan Schuurman; Rebecca A Nelson; Phillip R Rozak; Kate R Mueller; A N Balamurugan; Jeffrey D Ansite; Daniel W Fraga; Andrew S Friberg; Gina M Wildey; Tomohiro Tanaka; Connor A Lyons; David E R Sutherland; Bernhard J Hering; Klearchos K Papas
Journal:  Cell Transplant       Date:  2012-08-02       Impact factor: 4.064

View more
  2 in total

1.  In vitro generation of peri-islet basement membrane-like structures.

Authors:  Jorge Santini-González; Jennifer A Simonovich; Roberto Castro-Gutiérrez; Yarelis González-Vargas; Nicholas J Abuid; Cherie L Stabler; Holger A Russ; Edward A Phelps
Journal:  Biomaterials       Date:  2021-04-13       Impact factor: 15.304

2.  Efficient induction of pancreatic alpha cells from human induced pluripotent stem cells by controlling the timing for BMP antagonism and activation of retinoic acid signaling.

Authors:  Shigeharu G Yabe; Satsuki Fukuda; Junko Nishida; Fujie Takeda; Kiyoko Nashiro; Hitoshi Okochi
Journal:  PLoS One       Date:  2021-01-11       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.